InvestorsHub Logo
Followers 0
Posts 5
Boards Moderated 0
Alias Born 09/20/2009

Re: None

Sunday, 07/17/2011 12:18:06 AM

Sunday, July 17, 2011 12:18:06 AM

Post# of 92948
ACTC the "Best" option.

$20,000.00 for one eye, with ongoing treatment for this implant:

Of course it’s also after many long months of rehabilitation and occupational therapy. The IMT doesn’t treat AMD directly, it works around it. Incoming images are expanded onto the part of the macula that has yet to decay. Patients have to learn how to take that donut-like image and use it to see. If a patient has two eyes with AMD (which is often the case), one eye is kept un-implanted so that it can serve to pick up peripheral vision. It takes quite a bit of effort to adapt to this new kind of vision. Colby was quick to point out in our interview that not everyone with end-stage AMD will be a good candidate because of the stress of rehabilitation. There are also concerns with side effects such as corneal edema (swelling), and a small fraction, 1 out of 25 or so, will need a corneal transplant due to damage caused by the IMT. Yet for many over the age of 75, CentraSight represents a real opportunity to restore vision before it is lost completely. And as I’ve said, that opportunity is here now.



There is no promise with the CentraSight telescope implant. Rumors on the net are that it does not always make things better. Naturally for those it helps it is fantastic. But if ACTC can help in these cases, stem cells sure beat having an implant.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.